Jonathan Havens, partner in the law firm of Saul Ewing Arnstein & Lehr LLP, explains the causes of the current infant formula shortage, and discusses possible solutions to the crisis, both short- and long-term.
The pharmaceutical industry loses roughly $35 billion annually because of failures in temperature-controlled logistics. Those losses are almost entirely preventable.
Hospitals around the U.S. are postponing CT scans and rationing care while waiting on shipments of medical dye made in a Shanghai plant that just restarted production amid the city’s lockdown.
Abbott Laboratories reached a pact with U.S. authorities that would allow it to begin making baby formula again at a troubled plant in Michigan, a move that could help ease a supply shortfall that has rattled many parents.
At a time when companies will do just about anything to recruit and retain workers, fertility benefits have gone from novelty to a must-have for many companies.
The Biden administration will allow all pharmacies to order Pfizer Inc.’s COVID-19 therapy pill, as it looks to boost access to the promising drug as the supply increases.
The latest supply-chain news, analysis, trends and tools for executives in the healthcare industry. Learn how healthcare companies and their suppliers around the world are managing the flow of products across all channels of the enterprise. Experts sound off on forecasting and demand planning, supply-chain visibility, logistics outsourcing, inventory optimization, transportation management, warehouse management, supply-chain security, corporate social responsibility and more.
Subscribe to our Daily Newsletter!
Timely, incisive articles delivered directly to your inbox.